摘要
软组织肉瘤是一种少见的恶性肿瘤,术后易复发,晚期可出现脏器转移,放化疗不敏感,治疗难度大。中医学认为肉瘤的形成原因主要与人体正气亏虚,脏腑失调、气血功能失常有关,湿热痰毒瘀为其病理关键,主要病位在脾、肾、肝、肺,辨证分型并不统一;临床治疗研究多集中在个案及经验,可重复性差,系统的临床研究较少,需进一步通过多中心、大规模的临床研究来进行评价。在中医药理论指导下,开展软组织肉瘤证候分布演变规律研究、中医治则治法研究;在循证医学原则指导下,分病种开展多中心、大样本、随机对照临床研究对中医药治疗疗效进行客观评价很有必要。
Soft tissue sarcoma (STS) is a rare malignant tumor, easy to recur after operation, and organ me-tastasis could occur in late stage, insensitive for radiotherapy and chemotherapy, difficult to treat. According to the theory of Traditional Chinese medicine (TCM), the formation of sarcoma is mainly related to deficiency of vital Qi, imbalance of Zang-Fu and dysfunction of Qi and Blood, the key is phlegm, blood stasis, damp-heat to its pathology, and the main disease is in the spleen, kidney, liver and lung, and the syndrome differentiation is not unified. The clinical treatment research is focused on the case reports and experience, the repeatability is poor, the good clinical research is less. We should discuss the distribution and evolution of the syndrome distribution syndrome and pathogenesis of STS, the treatment principle and treatment method of TCM in STS. The multi-center, large sample and randomized controlled clinical study should be carried out in order to evaluate therapeutic effect of TCM treatment objectively.
出处
《中医学》
2018年第1期1-6,共6页
Traditional Chinese Medicine
